N-3 fatty acids for improvement of Respiratory Outcomes - The N3RO trial

Dataset

Description

This dataset includes 1244 preterm infants born at less than 29 weeks' gestation, within 3 days of first enteral feed were randomised (622 per group) to receive an enteral emulsion containing DHA or a control emulsion without DHA. The DHA emulsion provided 60 mg/kg/day of DHA. The study emulsions continued to 36 weeks' postmenstrual age (PMA). The primary outcome was bronchopulmonary dysplasia, as assessed by the requirement for supplemental oxygen and/or assisted ventilation at 36 weeks' PMA.
Date made available2023
PublisherSouth Australian Health and Medical Research Institute
Temporal coverage12 Jul 2012 - 22 May 2022
Date of data production2023
Geographical coverageSouth Australia Victoria Queensland Western Australia New South Wales

Cite this